JDHIF OTC
JD Health International Inc.
1W: +0.0%
1M: -9.7%
3M: -25.1%
YTD: -42.2%
1Y: -44.8%
3Y: -54.3%
5Y: -80.4%
$4.38
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$71.5B
+23.0% ▲
5Y CAGR: +29.8%
Gross Profit
$17.7B
+33.2% ▲
5Y CAGR: +29.2%
Operating Income
$3.7B
+150.2% ▲
Net Income
$5.2B
+25.8% ▲
EPS (Diluted)
$1.61
+22.0% ▲
EBITDA
$4.0B
-20.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $30.7B | $46.7B | $53.5B | $58.2B | $71.5B |
| YoY Growth | +58.3% | +52.3% | +14.5% | +8.6% | +23.0% |
| Cost of Revenue | $23.5B | $36.8B | $41.7B | $44.9B | $53.8B |
| Gross Profit | $7.2B | $9.9B | $11.9B | $13.3B | $17.7B |
| Gross Margin | 23.5% | 21.2% | 22.2% | 22.9% | 24.8% |
| R&D Expenses | $893M | $1.1B | $1.2B | $1.3B | $1.6B |
| SG&A Expenses | $7.7B | $4.3B | $4.7B | $4.5B | $12.3B |
| Operating Expenses | $8.6B | $9.9B | $11.2B | $11.8B | $14.0B |
| Operating Income | -$857M | $803M | $631M | $1.5B | $3.7B |
| Operating Margin | -2.8% | 1.7% | 1.2% | 2.5% | 5.2% |
| Interest Expense | $6M | $9M | $9M | $8M | $11M |
| Income Before Tax | -$901M | $696M | $2.7B | $4.8B | $5.9B |
| Tax Expense | $171M | $313M | $550M | $640M | $646M |
| Net Income | -$1.1B | $380M | $2.1B | $4.2B | $5.2B |
| Net Margin | -3.5% | 0.8% | 4.0% | 7.2% | 7.3% |
| EPS (Diluted) | $-0.35 | $0.12 | $0.68 | $1.32 | $1.61 |
| EBITDA | -$832M | $944M | $858M | $5.0B | $4.0B |
| Shares Outstanding | 3.09B | 3.14B | 3.16B | 3.16B | 3.20B |